Published online Jul 28, 2022. doi: 10.4329/wjr.v14.i7.180
Peer-review started: January 5, 2022
First decision: June 16, 2022
Revised: June 26, 2022
Accepted: July 6, 2022
Article in press: July 6, 2022
Published online: July 28, 2022
Processing time: 202 Days and 20.9 Hours
There is increasing evidence on the utility of cardiac computed tomography (CCT) in infective endocarditis (IE) to investigate the valvular pathology, the extra-cardiac manifestations of IE and pre-operative planning. CCT can assist in the diagnosis of perivalvular complications, such as pseudoaneurysms and abscesses, and can help identify embolic events to the lungs or systemic vasculature. CCT has also been shown to be beneficial in the pre-operative planning of patients by delineating the coronary artery anatomy and the major cardiovascular structures in relation to the sternum. Finally, hybrid nuclear/computed tomography techniques have been shown to increase the diagnostic accuracy in prosthetic valve endocarditis. This manuscript aims to provide a contemporary update of the existing evidence base for the use of CCT in IE.
Core Tip: Cardiac computed tomography (CCT) has an expanding role in the management of infective endocarditis (IE). It has been shown to be superior to echocardiography for diagnosing perivalvular complications such as pseudoaneurysms and abscesses. CCT can also diagnose extra-cardiac manifestations of IE such as septic emboli to the lungs. It can assist in pre-operative planning by delineating the coronary anatomy and assessing vascular structures. Herein, we review the role of CCT in IE including the evidence base comparing CCT to echocardiography in diagnosing the valvular complications of IE and the use of CT in IE beyond valvular assessment.